TrialPath
Recruiting

Evaluation of Fecal Multi-target Biomarkers in the Screening of Digestive Tract Cancers

NCT07600125 · Xijing Hospital
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Evaluation of Fecal Multi-target Biomarkers in the Screening of Digestive Tract Cancers: a Multi-center Prospective Observational Cohort Study
About this study
This study is a multi-center, observational study. Participants scheduled for gastroscopy and colonoscopy will undergo an epidemiological assessment and provide a stool sample prior to endoscopy for qualitative Fecal Immunochemical Test (FIT), quantitative Fecal Immunochemical Test (FIT), and novel biomarker testing, followed by the endoscopic examination. After completion of the baseline endoscopic screening, all enrolled participants will undergo a 2-year follow-up. The primary endpoints of the study are sensitivity and specificity for the screening of gastrointestinal cancers.The aim of this study is to develop and evaluate the sensitivity and specificity of fecal multi-marker panels for the screening of gastrointestinal cancers.
Eligibility criteria
Inclusion Criteria: 1. Participants must be at least 18 years of age at the time of enrollment; 2. Participants must be scheduled to undergo gastroscopy and colonoscopy; 3. Participants must agree to undergo a two-year follow-up as outlined in the protocol; 4. Participants must be willing to participate and sign an informed consent form. Exclusion Criteria: 1. Have undergone gastrointestinal endoscopy screening within the past year; 2. History of any type of gastrointestinal malignancy; 3. Concurrent severe medical conditions that reduce the benefits of screening, such as severe pulmonary disease, kidney disease, liver disease, cardiovascular and cerebrovascular diseases, and hematological disorders; 4. Other situations where a physician determines that endoscopic screening poses excessive risk (e.g., hemodynamic instability) or offers no benefit (e.g., short life expectancy); 5. Pregnant or breastfeeding women.
Study design
Enrollment target: 5000 participants
Age groups: adult, older_adult
Timeline
Starts: 2026-08-10
Estimated completion: 2027-12-31
Last updated: 2026-08-11
Interventions
Diagnostic Test: Qualitative Fecal Immunochemical Test (FIT), quantitative (FIT), and testing for new biomarkers
Primary outcomes
  • • Sensitivity and Specificity of Stool-Based Biomarker Testing for Gastrointestinal Cancer Screening (At the time of baseline endoscopic screening, approximately 2 weeks after stool sample collection.)
Sponsor
Xijing Hospital · other
Contacts & investigators
ContactZheng · contact · zhengrong4956@163.com · +86 198 2975 8242
All locations (13)
The First Affiliated Hospital of Air Force Military Medical UniversityRecruiting
Xi'an, Shaanxi, China
The First Affiliated Hospital of Dalian Medical UniversityRecruiting
Dalian, China
Hongxing Hospital of the 13th Division, Xinjiang Production and Construction CorpsRecruiting
Hami, China
Cao County People's HospitalRecruiting
Heze, China
The 960th Hospital of the Joint Support Force of the People's Liberation Army of ChinaRecruiting
Jinan, China
PetroChina Central Hospital, HebeiRecruiting
Langfang, China
Huoqiu County People's HospitalRecruiting
Liu‘an, China
Qingdao Municipal HospitalRecruiting
Qingdao, China
Central Theater Command General HospitalRecruiting
Wuhan, China
Wuwei Cancer Hospital of Gansu ProvinceRecruiting
Wuwei, China
Wuxi People's HospitalRecruiting
Wuxi, China
Gaoyao District People's Hospital, Zhaoqing City, Guangdong ProvinceRecruiting
Zhaoqing, China
Zhaoqing First People's Hospital, Guangdong ProvinceRecruiting
Zhaoqing, China
Evaluation of Fecal Multi-target Biomarkers in the Screening of Digestive Tract Cancers · TrialPath